Tue. 14 May 2024, 4:06pm ET
Benzinga
Earnings, Earnings Misses, News
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 10 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $1.38 million in sales this quarter. This is a 195.38 percent increase over sales of $466.18 thousand the same period last year.